Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | NASDAQ | Biotechnology | $39.77B | $359.05 | 1.18% | $318.03M | 7,181.00x | 0.85 | Cayman Islands | ||
| NVO | NOVO NORDISK A S | NYSE | Biotechnology | $219.81B | $49.23 | -0.28% | $24.13B | 13.49x | 1.80 | Denmark | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | NASDAQ | Biotechnology | $3.44B | $45.39 | 0.02% | $53.58M | 92.63x | 0.33 | Bermuda | ||
| ZVRA | ZEVRA THERAPEUTICS INC | NASDAQ | Biotechnology | $486.97M | $8.65 | 0.70% | $67.21M | 18.02x | 1.03 | United States | ||
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $4.19B | $39.82 | 0.48% | $65.98M | 39.82x | 0.30 | United States | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | $44.12B | $332.68 | 0.02% | $631.44M | 139.20x | 5.29 | United States | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $1.89B | $37.41 | 1.60% | $29.31M | 143.88x | 0.41 | United States | ||
| ARGX | ARGENX SE | NASDAQ | Biotechnology | $51.60B | $845.35 | 0.21% | $811.30M | 33.78x | 0.18 | Belgium | ||
| GMAB | GENMAB A | NASDAQ | Biotechnology | $18.73B | $29.16 | -2.80% | $1.54B | 18.81x | 1.20 | Denmark | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $8.28B | $283.29 | -1.58% | $196.02M | 40.01x | 0.09 | United States | ||
| LGND | LIGAND PHARMACEUTICALS INC | NASDAQ | Biotechnology | $3.74B | $189.94 | 1.30% | $103.01M | 82.23x | 0.55 | United States | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $9.28B | $59.33 | 1.42% | $226.43M | 114.10x | 0.25 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $3.81B | $15.99 | 0.25% | $172.13M | 18.17x | 0.32 | United States | ||
| MNKD | MANNKIND CORP | NASDAQ | Biotechnology | $1.67B | $5.44 | -1.81% | $73.18M | 54.40x | -12.10 | United States | ||
| ABEO | ABEONA THERAPEUTICS INC | NASDAQ | Biotechnology | $277.46M | $5.12 | 1.59% | $89.85M | 3.22x | 0.35 | United States | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $8.64B | $73.23 | -9.01% | $573.05M | 27.74x | 50.73 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $26.15B | $45.34 | -0.15% | $1.08B | 25.33x | 1.02 | United States | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $2.89B | $36.61 | 1.61% | $57.00M | 93.87x | 0.09 | United States | ||
| XOMA | XOMA ROYALTY CORP | NASDAQ | Biotechnology | $301.53M | $24.35 | -0.49% | $26.75M | 30.06x | 1.77 | United States | ||
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | $399.03M | $5.00 | -4.94% | $22.69M | 18.52x | 0.39 | United States | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | NYSEMKT | Biotechnology | $239.66M | $2.98 | 0.00% | $8.87M | 42.57x | 0.56 | Israel | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $2.03B | $35.28 | -4.44% | $269.64M | 10.92x | 0.45 | United States | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.99B | $24.29 | -1.42% | $323.88M | 13.57x | 0.14 | United States | ||
| AUPH | AURINIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $1.89B | $14.31 | 0.00% | $103.52M | 24.67x | 0.44 | Canada | ||
| APLS | APELLIS PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.81B | $22.20 | 2.92% | $93.37M | 63.43x | 1.64 | United States | ||
| CRMD | CORMEDIX INC | NASDAQ | Biotechnology | $564.92M | $7.17 | -0.55% | $112.26M | 3.16x | 1.01 | United States | ||
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $83.75B | $792.16 | -0.17% | $5.82B | 18.39x | 0.30 | United States | ||
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $20.50B | $476.05 | -1.32% | $1.77B | 16.72x | 0.12 | United States | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $11.88B | $61.83 | 3.14% | $772.70M | 22.73x | 0.26 | United States | ||
| ACAD | ACADIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $3.93B | $23.20 | 1.09% | $287.72M | 14.78x | 0.45 | United States | ||
| VRTX | VERTEX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $119.47B | $470.31 | -1.47% | $4.87B | 30.42x | 0.37 | United States | ||
| INVA | INNOVIVA INC | NASDAQ | Biotechnology | $1.77B | $23.66 | -0.80% | $214.76M | 12.52x | 0.42 | United States | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $11.55B | $44.47 | 0.88% | $994.49M | 15.44x | 0.32 | United States | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $773.09M | $5.22 | 1.16% | $69.21M | 18.64x | 0.34 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $20.50B | $102.99 | 1.81% | $1.76B | 15.63x | 0.35 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.